C4 Therapeutics vs Tharimmune
C4 Therapeutics vs Tharimmune, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: C4 Therapeutics is on 49/100 and Tharimmune on 53/100.
Where each one leads
C4 Therapeutics
- domain rating: 41/100 against 26/100
Tharimmune
- our overall score: 53/100 against 49/100
- agent readiness: 31/100 against 21/100
- funding raised: $540M against $371M
At a glance
| Measure | C4 Therapeutics | Tharimmune |
|---|---|---|
| What it is | Biopharmaceutical company developing novel cancer therapies using targeted protein degradation. | Biotechnology company developing novel immunotherapies for cancer. |
| Category | Biotech, Drug Discovery, Oncology, Clinical Trials | Biotech, MedTech, HealthTech, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Services |
| Founded | 2016 | 2017 |
| Headquarters | Boston, United States | Cambridge, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | C4 Therapeutics | Tharimmune |
|---|---|---|
| Employees | Not published | 13 |
| Total funding | $371M | $540M |
| Latest round | Series D | Not published |
| LinkedIn followers | Not published | 1,718 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | C4 Therapeutics | Tharimmune |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 49/100 | 53/100 |
| Traction | 40/100 | 51/100 |
| Team | 20/100 | 70/100 |
| Community | Not published | 15/100 |
| Search visibility | 3/100 | 22/100 |
| Quality | 68/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | F (31/100) |
| Domain ratingLink authority, 0-100 | 41/100 | 26/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | C4 Therapeutics | Tharimmune |
|---|---|---|
| Hosting | Google Cloud | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | WordPress | Webflow |
| Analytics | Google Analytics 4, Google Tag Manager | Not detected |
C4 Therapeutics vs Tharimmune: common questions
Which is better, C4 Therapeutics or Tharimmune?
On our 0-100 score Tharimmune rates higher (53/100 against 49/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do C4 Therapeutics and Tharimmune compare on the numbers?
C4 Therapeutics leads on domain rating (41/100 against 26/100). Tharimmune leads on our overall score (53/100 against 49/100), agent readiness (31/100 against 21/100), funding raised ($540M against $371M).
Read the full C4 Therapeutics review and pricing or the Tharimmune review and pricing. You can also browse other C4 Therapeutics alternatives we track.